SIRT2 and lung cancer: Upregulation of HRD1 in lung cancer patients leads to decreased SIRT2 expression and enhanced cell proliferation and tumorigenesis, and HRD1 and SIRT2 expression levels may serve as prognostic markers for lung cancer (Fig. 7E).